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E-mail addresses: chojw311@yonsei.ac.kr (J.W. ChoCuticle formation and molting are critical for the development of Caenorhabditis elegans. To under-
stand cuticle formation more clearly, we screened for suppressors in transgenic worms that
expressed dominant ROL-6 collagen proteins. The suro-1 mutant, which is mild dumpy, exhibited
a different ROL-6::GFP localization pattern compared to other Dpymutants. We identiﬁed mutations
in three suro-1 mutants, and found that suro-1 (ORF R11A5.7) encodes a putative zinc-carboxypep-
tidase homologue. The expression of this enzyme in the hypodermis and the genetic interactions
between this enzyme and other collagen-modifying enzyme mutants suggest a regulatory role in
collagen processing and cuticle organization for this novel carboxypeptidase. These ﬁndings aid
our understanding of cuticle formation during worm development.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction chondrogenic tissues [5]. OI is a generalized disorder of connectiveExtracellular matrix (ECM) is important in many biological pro-
cesses, including cell–cell interactions, signal transduction, cell
adhesion, and cancer metastasis. As a major component of ECM,
collagens and collagen-like proteins comprise superfamilies in var-
ious species. Collagen synthesis requires eight speciﬁc post-trans-
lational enzymes, some of which are attractive targets for the
development of drugs to inhibit collagen accumulation in ﬁbrotic
diseases [1]. To date, more than 1300 mutations have been charac-
terized in the human collagen genes in various diseases [2], includ-
ing osteogenesis imperfecta (OI), many chondrodysplasias, several
subtypes of Ehlers–Danlos syndrome, Alport syndrome, Bethlem
myopathy, certain subtypes of epidermolysis bullosa, Knobloch
syndrome, osteoporosis, arterial aneurysms, osteoarthrosis, and
intervertebral disc disease [1]. Collagen IV is directly involved in
a number of genetic and acquired disease such as Alport’s and
Goodpasture’s syndromes [3]. Knobloch syndrome is caused by
pathogenic mutations in the COL18A1 gene [4]. Mutations in
COL11A2 cause a non-ocular Stickler syndrome by affectingchemical Societies. Published by E
iology, Yonsei University, 134
blic of Korea. Fax: +82 2 363
), jaegal@ncc.re.kr (J. Shim).tissue characterized by fragile bones, and most cases of OI are
caused by mutations in type I collagen [6].
Caenorhabditis elegans is a powerful model to study ECM organi-
zation because development of the worm includes four molting
processes from L1 larva to adult, and each molting stage involves
destruction and synthesis of cuticles [7]. Mutations in collagen
and modifying enzyme genes result in defects ranging from abnor-
mal morphology such as Dpy (dumpy), Lon (long), and Bli (blister)
to lethality. C. elegans has approximately 175 cuticle collagens and
two basement membrane type IV collagens [2]. Most collagens are
synthesized by hypodermal cells and seam cells, except for two
basement membrane collagens which are synthesized by body
wall muscle cells [8]. These proteins are then secreted and assem-
bled on the apical surface of the hypodermis to form a complex
multi-layered structure [9,10]. The cuticle collagens are most sim-
ilar to the vertebrate non-ﬁbrillar FACIT (ﬁbril-associated collagens
with interrupted triple helices) collagens [11]. The collagen-modi-
fying enzymes in C. elegans include three hydroxylases, two glyco-
syltransferases, two proteinases to cleave the N and C propeptides,
oxidase to initiate crosslink formation, and protein disulﬁde isom-
erase (PDI) [12]. The identiﬁcation of new collagen-modifying
enzymes and their functions is in progress. Here, we identiﬁed a
novel carboxypeptidase that functions in cuticle formation and
body morphogenesis in C. elegans, possibly through collagen
processing.lsevier B.V. All rights reserved.
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2.1. C. elegans strains and culture
Wild-type N2 and mutant strains were cultured as described by
Brenner [13]. The integrated line jgIs4 [Ptpst-1::gfp, rol-6 (su1006)],
which expresses dominant ROL-6 mutant proteins that originated
from the rol-6 (su1006) mutant, was used for random mutagenesis.
GFP expression is driven strongly in the pharynx and weakly in the
intestine by the tpst-1 promoter in the Ptpst-1::gfp reporter used as
a transgenic marker [14]. The jgIs5 [ttx-3::gfp, rol-6::gfp] strain,
which expresses ROL-6 fused with a green ﬂuorescent protein
(GFP), was used for analyzing ROL-6 localization [15]. All inte-
grated lines were generated by UV irradiation of extrachromo-
somal lines and backcrossed 4 times to wild-type N2 males. The
dpy-5 (e61), dpy-10 (e128), dpy-11 (e224), dpy-18 (e364), dpy-20
(e1282), rol-6 (e187), rol-9 (sc148), and sqt-3 (sc8) mutants were
also used.
2.2. Mutagenesis and suro-1 mutant cloning
jgIs4 animals were mutagenized using ethyl methane sulfo-
nate (EMS, Sigma–Aldrich Chemicals). L4 worms were harvested
and treated with EMS (ﬁnal concentration 0.05 M) at 20 C for
4 h. The suro mutants were selected from 500 000 F2 progeny.
Three suro-1 mutants were out-crossed 5 times and rescued
with PCR fragments of R11A5.7 genomic DNA. The suro-1
(jg34) mutant was segregated from suro-1 (jg34) jgIs4 by crossing
with an N2 male. Both suro-1 and jgIs4 are located on chromo-
some I.Fig. 1. Rol suppressor screening and suro-1mutant phenotype. (A) The suromutants wer
1mutant is almost normal, but the suro-1mutant exhibits a mild dumpy phenotype. (B)
patterns in suro-1 and several Dpy mutants. DPY-10 and DPY-13 are collagens. DPY-11 is
propyl-4-hydoxylase. (D) COL-19::GFP in a suro-1 background exhibits an abnormal patte
abnormal ROL-6::GFP or COL-19::GFP patterns in the suro-1 mutant. WT = wild-type. Sc2.3. Reporter gene and deletion constructs
We made COL-19::GFP using the same genomic DNA region de-
scribed by the Page lab. [16] and the pPD95.77 GFP vector (Dr. An-
drew Fire). The Psuro-1::NLS::GFP construct was generated by PCR
of genomic DNA, which included the 50 upstream region (2 kb).
The PCR product was cloned into the PstI and BamHI sites of the
GFP vector (pPD95.69 from Dr. Andrew Fire), which has a SV40 nu-
clear localization signal (NLS). Full-length suro-1 cDNA was ampli-
ﬁed by RT-PCR using N2 mRNA as a template, and the fragment
was cloned into the pGEM-T Easy Vector (Promega). Deletion series
of suro-1 cDNA was ampliﬁed using speciﬁc primer sets, and the
resultant products were cloned into the pPD117.01 vector that in-
cluded the suro-1 promoter. The Prol-6::EMR-1::RFP construct was
generated for the hypodermal cell marker, and it included 1.7 kb
rol-6 promoter region and emr-1 cDNA. The rol-6 genomic DNA
was ampliﬁed by PCR (primer sequences: 50 atg cat gct tat cat ctt
cgg ttt tga t 30 and 50 att cta gac tgg aaa ttt tca gtt aga tct 30) and
the PCR product was cloned into the pPD95.77R vector which
has DsRed (Clontech) instead of GFP in the pPD95.77 vector using
the SphI and XbaI sites. The emr-1 cDNA was ampliﬁed by RT-PCR
(primer sequences: 50 agg atc cat gga cgt ctc cca gct g 30 and 50
ttt ccc ggg ata gta tcc tcc gga ttc gtc 30), and the PCR product was
cloned into the Prol-6::RFP construct using the BamHI and SmaI
sites. EMR-1 is a homolog of the human integral nuclear membrane
protein Emerin [17]. The SURO-1::RFP and SURO-1::GFP constructs
include the 50 upstream region (2 kb) and full-length genomic cod-
ing region of suro-1. The detailed method and primer sequences
used for these constructs are shown in the Supplementary data
(Fig. S1) and all constructs were conﬁrmed by sequencing.e screened by EMS mutagenesis of jgIs4, which expresses a dominant ROL-6. The sqt-
The alae phenotype is also suppressed by suromutations. (C) ROL-6::GFP expression
a membrane-associated thioredoxin-like protein and DPY-18 is the alpha subunit of
rn compared to wild-type pattern. Arrowheads indicate alae. White arrows indicate
ale bars, 300 lm (A) and 50 lm (B–D).
T.H. Kim et al. / FEBS Letters 585 (2011) 121–127 1232.4. Microinjection and RNAi
The genomic PCR products, including the R11A5.7 ORF, were
ampliﬁed and puriﬁed using a gel extraction kit. The PCR products
(50 lg/ml) were mixed with the injection marker ttx-3::gfp (75 lg/
ml) and injected into suro-1mutants. For the domain analysis, each
construct (75 lg/ml) with ttx-3::gfp (75 lg/ml) was injected into
suro-1 (jg34). The concentration of the suro-1 reporter DNAmixture
for microinjection was the same (150 lg/ml). For suro-1 RNAi, full-
length cDNA was transferred to the L4440 vector. Feeding RNAi
was carried out as described by Kamath et al. [18].
2.5. SURO-1::GFP expression in HeLa cells
To observe subcellular localization of SURO-1::GFP in HeLa
cells, PCR products for full-length suro-1 cDNA were digested with
XhoI and PstI and then ligated into the pEGFP-N1 expression vector
(Clontech Ltd.). For ﬂuorescence microscopy, cells were cultured
on slide glasses and transfected with 2 lg of suro-1::gfp DNA perFig. 2. SURO-1 is a zinc-carboxypeptidase homologue. (A) Genetic mapping of the suro-1
Amino acid sequence of SURO-1. SURO-1 has a propeptidase (Pro-pep), zinc carboxypepti
show each domain, and boxed sequences indicate a zinc-binding motif.well using lipofectamine (Lipofectamine 2000™; Invitrogen) and
manufacturer’s protocol. Cells were incubated with mounting solu-
tion containing DAPI (Vector Laboratories). All microscopic images
were captured using Axioplan 2 ﬂuorescence microscope and Axi-
ovision Rel.4.5 software (Zeiss).
3. Results
3.1. Mutant screen for novel genes involved in cuticle formation
Our previous work focused on the regulation of ROL-6 collagen
secretion by tyrosylprotein sulfotransferase (TPST-1) [15]; how-
ever, many questions still remain in understanding collagen regu-
lation and cuticle formation. ROL-6 is a cuticle collagen named for
the rolling phenotype of certain rol-6 mutants; the recessive rol-6
(e187) and dominant rol-6 (su1006) alleles show a ‘‘roller’’ pheno-
type where animals roll due to a twisted cuticle [19]. Although a
suppressor study with a rol-6 mutant has been already reported,
mainly intragenic suppressors were identiﬁed [19]. In this study,mutant. Sequencing results identiﬁed point mutations in three suro-1 mutants. (B)
dase, threonine-rich domain (THR), and Shk toxin (ShkT) domains. Bolded sequences
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rol-6 transgenes [rol-6 (su1006)] to identify new genes involved in3collagen processing and trafﬁcking. These Rol suppressors were
named suro (SUppressor ROl) mutants, and 47 suro mutants were
isolated from the 500 000 F2 animals screened (data not shown).
The sqt-1 mutant, a well-known rol-6 suppressor [19], was also
identiﬁed in our screen (Fig. 1A). Here, we describe the character-
ization of one of the isolated mutants, which was named suro-1.
suro-1 animals show a mild Dpy phenotype, as do mutants of many
other genes which suppress the Rol phenotype. The orientation of
alae in rolling worms is not parallel to worm body lines; however,
suro-1 and sqt-1 mutants showed normal alae orientation, similar
to wild-type (Fig. 1B).
At ﬁrst, we compared the ROL-6 localization at the cuticle in
suro-1 and other Dpy mutants by expressing ROL-6::GFP in these
mutants. All three suro-1 and the other Dpy mutants exhibited a
unique ROL-6::GFP localization pattern that differed from wild-
type. The stripes of ROL-6::GFP in the suro-1 mutant were discon-
tinuous in the middle of the region distal to the alae (20/20 (100%)
animals) (Fig. 1C and Fig. S2). We examined another collagen,
COL-19, to determine whether suro-1 affects localization of other
collagens. COL-19 is an adult-speciﬁc collagen, and COL-19 repor-
ter fusion protein is expressed strongly at the cuticle [16]. The
COL-19::GFP localization pattern was also changed in the suro-1
mutant background. The spaces between COL-19::GFP stripes were
irregular and some COL-19::GFP stripes leaned in the suro-1 mu-
tant (Fig. 1D).
Next, we generated a suro-1 (jg34); rol-6 (e187) double mutant
to test whether suro-1 could suppress the loss-of-function (lf) rol-
6 mutant. The suro-1 mutant suppressed the Rol phenotype of
rol-6 (e187). In addition, suro-1 suppressed other Rol mutants
including rol-9 (sc148) and sqt-3 (sc8) (Fig. S3 and data not shown).
ROL-9 has not been molecularly identiﬁed yet, while SQT-3 is a
cuticle collagen. Therefore, the suro-1 mutation appears to broadly
affect cuticle organization.
3.2. SURO-1 is a zinc-carboxypeptidase homologue
To identify the mutated gene of the suro-1mutant, we used SNP
mapping with the CB4856 strain. The suro-1 gene was mapped at
2.38 of chromosome I and rescued by PCR products including
R11A5.7. Sequencing of genomic DNA from suro-1mutants also re-
vealed mutations in R11A5.7. R11A5.7 encodes a putative zinc car-
boxypeptidase protein with a propeptide, carboxypeptidase,
threonine-rich (THR), and Shk toxin (ShkT) domains. The mutation
sites of suro-1 mutants were located in a conserved propeptide
cleavage site, carboxypeptidase domain, and THR domain, respec-
tively. Two mutations were missense mutations (jg34 and jg43),
and one mutation (jg33) in the splicing donor site resulted in an
early stop codon (Fig. 2 and Fig. S4). We performed rescue experi-
ments using the suro-1 (jg33) mutant and three mutant suro-1
cDNA constructs expressed under the control of the suro-1Fig. 3. Expression patterns and domain study of SURO-1. (A) Transgenic worms
expressing NLS::GFP under the control of the suro-1 promoter exhibited GFP signals
in the nuclei of hypodermis and intestine from 3-fold stage embryo to adult stages.
Upper panels show GFP, and lower panels are DIC images. M indicates a TTX-3::GFP
marker, and I indicates an intestinal nucleus. H indicates relatively small nuclei of
the hypodermal cells. Scale bars, 50 lm (L1) and 100 lm (L4). (B) Transgenic worms
containing the Psuro-1::NLS::GFP and Prol-6::EMR-1::RFP DNAs express NLS::GFPs
and EMR-1::RFPs in the same cells. EMR-1::RFPs are localized at the nuclear
envelope. Arrows indicate some hypodermal nuclei. Scale bar, 50 lm. (C) SURO-
1::RFPs are seen in many spots in the cytoplasm and located at the cuticle in C.
elegans. H indicates some nuclei of the hypodermal cells and arrows indicate SURO-
1::RFP spots around nuclei (early L4 larva). Scale bar, 50 lm. Most H33342
(Hoechst33342) stained nuclei (large blue circles) are hypodermal, and small blue
spots are non-speciﬁc staining of gut granules in this picture. (D) Mutations of suro-
1 do not affect intracellular trafﬁcking of SURO-1::GFPs in HeLa cells. SURO-1::GFP
is green and DAPI is blue. Scale bar, 100 lm.
Fig. 4. Genetic interaction of suro-1with other collagen-modifying enzyme mutants. (A) RNAi of suro-1 enhanced the Dpy phenotype of dpy-11 and dpy-18mutants. Average
body lengths and worm numbers counted are indicated in each picture. Errors are standard deviation, and P values (<0.001) between control RNAi and suro-1 RNAi of wild-
type worms, dpy-11 and dpy-18mutants were validated by Student’s t-test. (B) RNAi of suro-1 affected the cuticle structures of dpy-11 and dpy-18mutants. An Escherichia coli
clone containing the L4440 empty vector was used as a control. Arrowheads indicate alae. WT = wild-type. Scale bars, 300 lm (A) and 50 lm (B).
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cue Rol and Dpy phenotypes of suro-1 (Fig. S5A). This result and
similar ROL-6::GFP patterns among suro-1 mutants (Fig. S2) sug-
gest that three suro-1 mutations are almost null or loss-of-
function.
If SURO-1 functions in regulating collagen processing, this pro-
tein should be expressed in the hypodermal cells. Thus, we made
transgenic worms expressing NLS::GFP under the control of the
suro-1 promoter. In this case, GFP was expressed in nuclei of the
hypodermal cells and in some intestinal cells. The GFP signal was
detected from 3-fold stage embryos to young adult (Fig. 3A), and
was exactly co-localized with EMR-1::RFP which was expressed
under the control of the rol-6 promoter (Fig. 3B).
Furthermore, we examined the subcellular localization and traf-
ﬁcking of SURO-1 by expressing SURO-1::RFP in C. elegans. The RFP
signal was generally difﬁcult to detect; however, some larvae were
observed to showed SURO-1::RFP expression as multiple spots in
the hypodermal cells and as stripes at the cuticle (Fig. 3C). The sub-
cellular localization of SURO-1::GFP was also examined in HeLa
cells. SURO-1::GFP in the HeLa cells exhibited well-organized
patterns similar to SURO-1::RFP expression in the cytoplasm of
C. elegans hypodermal cells. Three mutant SURO-1::GFP forms,
which mimic three suro-1 mutations, were transfected into HeLa
cells to determine whether these mutations affect SURO-1 trafﬁck-
ing. All three mutant SURO-1::GFPs yielded patterns in the cyto-
plasm similar to the wild-type control (Fig. 3D).
3.3. Genetic interaction with other collagen-modifying enzyme
mutants
C. elegans has many zinc carboxypeptidases, but only a few of
these genes have a ShkT domain. ZC434.9, T06A4.3, and
Y47G6A.19 contain a ShkT domain but do not have a long THR
domain like SURO-1. We sought to determine the domains in
suro-1 that is necessary for proper body morphogenesis. Thus,
we made a deletion series of SURO-1 expressed under the control
of the suro-1 promoter, and performed rescue experiments using
the suro-1 mutant. Several full-length SURO-1 constructs, includ-
ing suro-1 genomic DNA, cDNA and two GFP-fusions, rescued the
suro-1 mutant phenotype completely; however, the SURO-1
deletion constructs did not complement the phenotypes of suro-
1 (Fig. S5B). Therefore, all domains are possibly needed for
SURO-1 function in body morphogenesis.
SURO-1 seemingly functions in collagen processing and modiﬁ-
cation; thus, this protein likely differs from other collagen-modify-
ing enzymes in functional steps or in substrates. In order to
elucidate the genetic interaction between suro-1 and other colla-
gen-modifying enzyme mutants, suro-1 RNAi was fed to dpy-11
and dpy-18 mutants. Knockdown of suro-1 in a wild-type back-
ground using feeding RNAi resulted in a mild Dpy phenotype and
an abnormal ROL-6::GFP pattern, similar to that seen in the suro-
1 mutant, and suro-1 RNAi resulted in an additive effect on the
Dpy phenotype in other Dpy backgrounds (Fig. 4A and data not
shown). We also observed changes in cuticle organization using
ROL-6::GFP. Interestingly, suro-1 RNAi resulted in differences be-
tween dpy-11 and dpy-18 in contrast to the Dpy phenotype. The
suro-1 RNAi abolished the ROL-6::GFP stripes that were proximal
to alae in dpy-11, but this treatment sharpened and clariﬁed the
proximal ROL-6::GFP stripes in dpy-18 (Fig. 4B).
4. Discussion
SURO-1 is similar to the mammalian carboxypeptidase A (CPA)
family, and this protein functions in cuticle formation and body
morphogenesis according to the analysis of its mutant phenotype.The facts that SURO-1 is expressed in the hypodermis and has ge-
netic interaction with other collagen-modifying enzyme mutants
also support this function; however, questions about the sub-
strates and the ﬁnal localization of this protein remain.
More than ﬁve paralogues of SURO-1/CPA exist in the C. elegans
genome; therefore, target identiﬁcation is very important in order
to understand the function of these enzymes. CPA may function
after the cleavage of substrate proteins by an endopeptidase such
as DPY-31, which cleaves the C-terminal region of procollagens
[20], because we expect that the relationship of DPY-31 and
SURO-1/CPA in collagen processing is similar to that of EGL-3/
PC2 and EGL-21/CPE in neuropeptide processing [21]. Both SQT-3
and DPY-13 have a putative DPY-31 cleavage site in the C-terminal
domain [20]. In addition, SQT-3 is suppressed by suro-1 mutation.
Since dpy-13 does not exhibit an additive phenotype following
suro-1 RNAi treatment, this mutant may belong to the same path-
way as suro-1 (data not shown). We propose that SQT-3 and DPY-
13 are potential SURO-1 target proteins.
Collagen processing and cuticle formation is composed of multi-
ple steps; thus, it is very important to elucidate the site of SURO-1
function including processing and activation of SURO-1. As an ef-
fort to reveal this, we tried to determine the subcellular localiza-
tion of SURO-1 in C. elegans using SURO-1::RFP. Since SURO-
1::RFP is expressed in vesicle-like structures in the hypodermal
cells and also observed to be localized at the cuticle, we expect that
SURO-1 would function in a transport vesicle or at the ECM
(Fig. 3C). In addition, the function of SURO-1 is possibly associated
with DPY-31 which has a putative role in SQT-3 extracellular pro-
cessing [22].
Although CPAs have been reported to be associated with many
human diseases including mast cell disease and several cancers
[23–25], their exact in vivo functions are not known well. In this
study, we reported a novel CPA and used genetic analysis to dem-
onstrate its function in cuticle formation and body morphogenesis
in C. elegans. We expect that this study will be useful in under-
standing the complex mechanism of collagen processing and cuti-
cle formation by identifying a new enzyme that is involved in these
processes.
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